ms21

MS21570 作为 GPR171 拮抗剂基于其阻断能力，IC50 为 220 nM，可减少小鼠的焦虑样行为和恐惧条件反射。

IMS2186 是一种抗脉络膜新生血管 (CNV) 试剂， 可以使癌细胞周期阻滞在 G2 M 期，由此产生抗增殖和抗血管生成作用。IMS2186 能够减少眼睛渗漏和病变细胞的数量，并且无眼内毒性。

MS21 is a unique AKT degrader that selectively hampers the proliferation of cancers with mutations in the PI3K/PTEN pathway, alongside wild-type KRAS and BRAF.

MS2126 is a Human p53 and CREB Binding Protein interaction inhibitor.

MS2177 is a potent and selective inhibitor of SETD8, the only methyltransferase known to catalyze monomethylation of histone H4 lysine 20 (H4K20). MS2177 has an in vitro IC50 of 1.9 μM (σ = 1.05 μM, n = 4) in ascintillation proximity assay. Binding of MS2